1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Digital Biomarker Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-6Y6173
Home | Market Reports | Health| Nursing
Global Digital Biomarker Market Insights and Forecast to 2028
BUY CHAPTERS

Global Digital Biomarker Market Research Report 2024

Code: QYRE-Auto-6Y6173
Report
February 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Digital Biomarker Market Size

The global Digital Biomarker market was valued at US$ 387.2 million in 2023 and is anticipated to reach US$ 22360 million by 2030, witnessing a CAGR of 82.5% during the forecast period 2024-2030.

Digital Biomarker Market

Digital Biomarker Market

Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.
Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.
This report aims to provide a comprehensive presentation of the global market for Digital Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Biomarker.

Report Scope

The Digital Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Digital Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Digital Biomarker Market Report

Report Metric Details
Report Name Digital Biomarker Market
Accounted market size in 2023 US$ 387.2 million
Forecasted market size in 2030 US$ 22360 million
CAGR 82.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Passive Digital Biomarker
  • Active Digital Biomarker
Segment by Application
  • Clinical Disease
  • Daily Health
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Apple, Sanofi, GlaxoSmithKline, Bayer, Merck, Abbott Laboratories, Asahi Kasei, Biogen, Koneksa Health, Roche, Huma Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Digital Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Digital Biomarker Market growing?

Ans: The Digital Biomarker Market witnessing a CAGR of 82.5% during the forecast period 2024-2030.

What is the Digital Biomarker Market size in 2030?

Ans: The Digital Biomarker Market size in 2030 will be US$ 22360 million.

What is the market share of major companies in Digital Biomarker Market?

Ans: Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share.

What is the Digital Biomarker Market share by type?

Ans: In terms of type, passive digital biomarker segment holds an important share of about 65%.

What is the Digital Biomarker Market share by application?

Ans: In terms of application, clinical disease segment accounts for about 80% of the total share.

Who are the main players in the Digital Biomarker Market report?

Ans: The main players in the Digital Biomarker Market are Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Apple, Sanofi, GlaxoSmithKline, Bayer, Merck, Abbott Laboratories, Asahi Kasei, Biogen, Koneksa Health, Roche, Huma Therapeutics

What are the Application segmentation covered in the Digital Biomarker Market report?

Ans: The Applications covered in the Digital Biomarker Market report are Clinical Disease, Daily Health

What are the Type segmentation covered in the Digital Biomarker Market report?

Ans: The Types covered in the Digital Biomarker Market report are Passive Digital Biomarker, Active Digital Biomarker

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Passive Digital Biomarker
1.2.3 Active Digital Biomarker
1.3 Market by Application
1.3.1 Global Digital Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Disease
1.3.3 Daily Health
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Biomarker Market Perspective (2019-2030)
2.2 Digital Biomarker Growth Trends by Region
2.2.1 Global Digital Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Digital Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Digital Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Digital Biomarker Market Dynamics
2.3.1 Digital Biomarker Industry Trends
2.3.2 Digital Biomarker Market Drivers
2.3.3 Digital Biomarker Market Challenges
2.3.4 Digital Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Biomarker Players by Revenue
3.1.1 Global Top Digital Biomarker Players by Revenue (2019-2024)
3.1.2 Global Digital Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Digital Biomarker Revenue
3.4 Global Digital Biomarker Market Concentration Ratio
3.4.1 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Biomarker Revenue in 2023
3.5 Digital Biomarker Key Players Head office and Area Served
3.6 Key Players Digital Biomarker Product Solution and Service
3.7 Date of Enter into Digital Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Biomarker Breakdown Data by Type
4.1 Global Digital Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Digital Biomarker Forecasted Market Size by Type (2025-2030)
5 Digital Biomarker Breakdown Data by Application
5.1 Global Digital Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Digital Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Digital Biomarker Market Size (2019-2030)
6.2 North America Digital Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Digital Biomarker Market Size by Country (2019-2024)
6.4 North America Digital Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Biomarker Market Size (2019-2030)
7.2 Europe Digital Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Digital Biomarker Market Size by Country (2019-2024)
7.4 Europe Digital Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Digital Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Digital Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Digital Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Biomarker Market Size (2019-2030)
9.2 Latin America Digital Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Digital Biomarker Market Size by Country (2019-2024)
9.4 Latin America Digital Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Digital Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Digital Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Digital Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Philips
11.1.1 Philips Company Detail
11.1.2 Philips Business Overview
11.1.3 Philips Digital Biomarker Introduction
11.1.4 Philips Revenue in Digital Biomarker Business (2019-2024)
11.1.5 Philips Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Digital Biomarker Introduction
11.2.4 Johnson & Johnson Revenue in Digital Biomarker Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Digital Biomarker Introduction
11.3.4 Pfizer Revenue in Digital Biomarker Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Detail
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Digital Biomarker Introduction
11.4.4 GE Healthcare Revenue in Digital Biomarker Business (2019-2024)
11.4.5 GE Healthcare Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Digital Biomarker Introduction
11.5.4 Novartis Revenue in Digital Biomarker Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Apple
11.6.1 Apple Company Detail
11.6.2 Apple Business Overview
11.6.3 Apple Digital Biomarker Introduction
11.6.4 Apple Revenue in Digital Biomarker Business (2019-2024)
11.6.5 Apple Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Digital Biomarker Introduction
11.7.4 Sanofi Revenue in Digital Biomarker Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Digital Biomarker Introduction
11.8.4 GlaxoSmithKline Revenue in Digital Biomarker Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Digital Biomarker Introduction
11.9.4 Bayer Revenue in Digital Biomarker Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Digital Biomarker Introduction
11.10.4 Merck Revenue in Digital Biomarker Business (2019-2024)
11.10.5 Merck Recent Development
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Detail
11.11.2 Abbott Laboratories Business Overview
11.11.3 Abbott Laboratories Digital Biomarker Introduction
11.11.4 Abbott Laboratories Revenue in Digital Biomarker Business (2019-2024)
11.11.5 Abbott Laboratories Recent Development
11.12 Asahi Kasei
11.12.1 Asahi Kasei Company Detail
11.12.2 Asahi Kasei Business Overview
11.12.3 Asahi Kasei Digital Biomarker Introduction
11.12.4 Asahi Kasei Revenue in Digital Biomarker Business (2019-2024)
11.12.5 Asahi Kasei Recent Development
11.13 Biogen
11.13.1 Biogen Company Detail
11.13.2 Biogen Business Overview
11.13.3 Biogen Digital Biomarker Introduction
11.13.4 Biogen Revenue in Digital Biomarker Business (2019-2024)
11.13.5 Biogen Recent Development
11.14 Koneksa Health
11.14.1 Koneksa Health Company Detail
11.14.2 Koneksa Health Business Overview
11.14.3 Koneksa Health Digital Biomarker Introduction
11.14.4 Koneksa Health Revenue in Digital Biomarker Business (2019-2024)
11.14.5 Koneksa Health Recent Development
11.15 Roche
11.15.1 Roche Company Detail
11.15.2 Roche Business Overview
11.15.3 Roche Digital Biomarker Introduction
11.15.4 Roche Revenue in Digital Biomarker Business (2019-2024)
11.15.5 Roche Recent Development
11.16 Huma Therapeutics
11.16.1 Huma Therapeutics Company Detail
11.16.2 Huma Therapeutics Business Overview
11.16.3 Huma Therapeutics Digital Biomarker Introduction
11.16.4 Huma Therapeutics Revenue in Digital Biomarker Business (2019-2024)
11.16.5 Huma Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Digital Biomarker Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Passive Digital Biomarker
    Table 3. Key Players of Active Digital Biomarker
    Table 4. Global Digital Biomarker Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Digital Biomarker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Digital Biomarker Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Digital Biomarker Market Share by Region (2019-2024)
    Table 8. Global Digital Biomarker Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Digital Biomarker Market Share by Region (2025-2030)
    Table 10. Digital Biomarker Market Trends
    Table 11. Digital Biomarker Market Drivers
    Table 12. Digital Biomarker Market Challenges
    Table 13. Digital Biomarker Market Restraints
    Table 14. Global Digital Biomarker Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Digital Biomarker Market Share by Players (2019-2024)
    Table 16. Global Top Digital Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Biomarker as of 2023)
    Table 17. Ranking of Global Top Digital Biomarker Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Digital Biomarker Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Digital Biomarker Product Solution and Service
    Table 21. Date of Enter into Digital Biomarker Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Digital Biomarker Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Digital Biomarker Revenue Market Share by Type (2019-2024)
    Table 25. Global Digital Biomarker Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Digital Biomarker Revenue Market Share by Type (2025-2030)
    Table 27. Global Digital Biomarker Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Digital Biomarker Revenue Market Share by Application (2019-2024)
    Table 29. Global Digital Biomarker Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Digital Biomarker Revenue Market Share by Application (2025-2030)
    Table 31. North America Digital Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Digital Biomarker Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Digital Biomarker Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Digital Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Digital Biomarker Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Digital Biomarker Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Digital Biomarker Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Digital Biomarker Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Digital Biomarker Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Digital Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Digital Biomarker Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Digital Biomarker Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Digital Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Digital Biomarker Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Digital Biomarker Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Philips Company Detail
    Table 47. Philips Business Overview
    Table 48. Philips Digital Biomarker Product
    Table 49. Philips Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 50. Philips Recent Development
    Table 51. Johnson & Johnson Company Detail
    Table 52. Johnson & Johnson Business Overview
    Table 53. Johnson & Johnson Digital Biomarker Product
    Table 54. Johnson & Johnson Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 55. Johnson & Johnson Recent Development
    Table 56. Pfizer Company Detail
    Table 57. Pfizer Business Overview
    Table 58. Pfizer Digital Biomarker Product
    Table 59. Pfizer Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 60. Pfizer Recent Development
    Table 61. GE Healthcare Company Detail
    Table 62. GE Healthcare Business Overview
    Table 63. GE Healthcare Digital Biomarker Product
    Table 64. GE Healthcare Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 65. GE Healthcare Recent Development
    Table 66. Novartis Company Detail
    Table 67. Novartis Business Overview
    Table 68. Novartis Digital Biomarker Product
    Table 69. Novartis Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 70. Novartis Recent Development
    Table 71. Apple Company Detail
    Table 72. Apple Business Overview
    Table 73. Apple Digital Biomarker Product
    Table 74. Apple Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 75. Apple Recent Development
    Table 76. Sanofi Company Detail
    Table 77. Sanofi Business Overview
    Table 78. Sanofi Digital Biomarker Product
    Table 79. Sanofi Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 80. Sanofi Recent Development
    Table 81. GlaxoSmithKline Company Detail
    Table 82. GlaxoSmithKline Business Overview
    Table 83. GlaxoSmithKline Digital Biomarker Product
    Table 84. GlaxoSmithKline Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 85. GlaxoSmithKline Recent Development
    Table 86. Bayer Company Detail
    Table 87. Bayer Business Overview
    Table 88. Bayer Digital Biomarker Product
    Table 89. Bayer Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 90. Bayer Recent Development
    Table 91. Merck Company Detail
    Table 92. Merck Business Overview
    Table 93. Merck Digital Biomarker Product
    Table 94. Merck Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 95. Merck Recent Development
    Table 96. Abbott Laboratories Company Detail
    Table 97. Abbott Laboratories Business Overview
    Table 98. Abbott Laboratories Digital Biomarker Product
    Table 99. Abbott Laboratories Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 100. Abbott Laboratories Recent Development
    Table 101. Asahi Kasei Company Detail
    Table 102. Asahi Kasei Business Overview
    Table 103. Asahi Kasei Digital Biomarker Product
    Table 104. Asahi Kasei Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 105. Asahi Kasei Recent Development
    Table 106. Biogen Company Detail
    Table 107. Biogen Business Overview
    Table 108. Biogen Digital Biomarker Product
    Table 109. Biogen Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 110. Biogen Recent Development
    Table 111. Koneksa Health Company Detail
    Table 112. Koneksa Health Business Overview
    Table 113. Koneksa Health Digital Biomarker Product
    Table 114. Koneksa Health Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 115. Koneksa Health Recent Development
    Table 116. Roche Company Detail
    Table 117. Roche Business Overview
    Table 118. Roche Digital Biomarker Product
    Table 119. Roche Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 120. Roche Recent Development
    Table 121. Huma Therapeutics Company Detail
    Table 122. Huma Therapeutics Business Overview
    Table 123. Huma Therapeutics Digital Biomarker Product
    Table 124. Huma Therapeutics Revenue in Digital Biomarker Business (2019-2024) & (US$ Million)
    Table 125. Huma Therapeutics Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Digital Biomarker Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Digital Biomarker Market Share by Type: 2023 VS 2030
    Figure 3. Passive Digital Biomarker Features
    Figure 4. Active Digital Biomarker Features
    Figure 5. Global Digital Biomarker Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Digital Biomarker Market Share by Application: 2023 VS 2030
    Figure 7. Clinical Disease Case Studies
    Figure 8. Daily Health Case Studies
    Figure 9. Digital Biomarker Report Years Considered
    Figure 10. Global Digital Biomarker Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Digital Biomarker Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Digital Biomarker Market Share by Region: 2023 VS 2030
    Figure 13. Global Digital Biomarker Market Share by Players in 2023
    Figure 14. Global Top Digital Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Biomarker as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Digital Biomarker Revenue in 2023
    Figure 16. North America Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Digital Biomarker Market Share by Country (2019-2030)
    Figure 18. United States Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. Canada Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Europe Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Digital Biomarker Market Share by Country (2019-2030)
    Figure 22. Germany Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. France Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. U.K. Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Italy Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Russia Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Nordic Countries Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Asia-Pacific Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Digital Biomarker Market Share by Region (2019-2030)
    Figure 30. China Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Japan Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. South Korea Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Southeast Asia Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. India Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Australia Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Latin America Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Digital Biomarker Market Share by Country (2019-2030)
    Figure 38. Mexico Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Brazil Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Digital Biomarker Market Share by Country (2019-2030)
    Figure 42. Turkey Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Saudi Arabia Digital Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Philips Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 45. Johnson & Johnson Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 46. Pfizer Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 47. GE Healthcare Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 48. Novartis Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 49. Apple Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 50. Sanofi Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 51. GlaxoSmithKline Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 52. Bayer Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 53. Merck Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 54. Abbott Laboratories Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 55. Asahi Kasei Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 56. Biogen Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 57. Koneksa Health Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 58. Roche Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 59. Huma Therapeutics Revenue Growth Rate in Digital Biomarker Business (2019-2024)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Hospice Software Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Geriatric Care Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Organ Preservation Technology Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8W13102
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Haemorrhoidal Energy Therapy (HET) Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17Q15432
Thu May 16 00:00:00 UTC 2024

Add to Cart